Vanguard (Lagos)
16 December 2008
The most clinically advanced malaria vaccine that is capable of reducing the incidence of malaria by more than 50 per cent in African infants and young children, may be licenced for use by 2011 if results of the final efficacy study commence early next year are anything to go by.
[ See Article ]
